Showing results (111-120 of 171) with videos related to
Sort By:
Pageof 18
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 15, 2013
Enteropathy associated T cell lymphoma in celiac disease: a large retrospective studyGeorgia Malamut, Olivia Chandesris, Virginie Verkarre, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2010
Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapyJean-François Rahier, Sébastien Buche, Laurent Peyrin-Biroulet, et al.Journal of Crohn'S & Colitis|April 13, 2016
Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's DiseasePhilippe Marteau, David Laharie, Jean-Frédéric Colombel, et al.Gut|April 25, 2012
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegolXavier Hébuterne, Marc Lémann, Yoram Bouhnik, et al.The American Journal of Gastroenterology|December 13, 2018
Oral Antibiotics Reduce Intestinal Necrosis in Acute Mesenteric Ischemia: A Prospective Cohort StudyAlexandre Nuzzo, Leon Maggiori, Catherine Paugam-Burtz, et al.The American Journal of Gastroenterology|August 6, 2014
Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAIDAurelien Amiot, Vida Setakhr, Philippe Seksik, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 25, 2024
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER StudyGuillaume Bouguen, Laure Gossec, Vered Abitbol, et al.Gastroenterology|August 14, 2012
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's diseasePierre Desreumaux, Arnaud Foussat, Matthieu Allez, et al.Alimentary Pharmacology & Therapeutics|June 21, 2021
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohortMathieu Uzzan, Clément Bresteau, David Laharie, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 17, 2019
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitisLoriane Lair-Mehiri, Carmen Stefanescu, Thibaut Vaysse, et al.Pageof 18